Receptor subtypes or species homologues: relevance to drug discovery

doi:10.1016/0165-6147(93)90096-3

Trends in Pharmacological Sciences

Volume 14, Issue 10, October 1993, Pages 376-383

https://doi.org/10.1016/0165-6147(93)90096-3 Get rights and content

Abstract

Cell surface receptors are targets for the pharmacological manipulation of physiological processes and thus represent a key direction for the development of selective therapeutic agents. Traditional pharmacological techniques, together with the development of synthetic ligands, have led to the identification of differences in receptor recognition properties and the proposal of multiple receptor subtypes. Molecular biological studies have confirmed the existence of receptor subtypes within a single species by demonstrating differences in receptor primary sequences. However, equivalent receptors between species also show differences in primary structure, albeit to a much lower degree. This review by Judith Hall and colleagues addresses the question of how differences in receptor primary structure between species relate to changes in pharmacology. The relevance of this to the choice of screens in the testing of potential therapeutic drugs is discussed.

References (29)

K.J. Watling et al.
Trends Pharmacol. Sci.
(1993)
S. Guard et al.
Neurochem. Int.
(1991)
N.P. Gerard et al.
Regul. Peptides
(1993)
T.M. Fong et al.
Nature
(1992)
B.S. Sachais et al.
J. Biol. Chem.
(1993)
C. Advenier
Biochem. Biophys. Res. Commun.
(1992)
F. Petitet et al.
Biochem. Biophys. Res. Commun.
(1993)
M.P. Caulfield
Pharmacol. Ther.
(1993)
A.D. Fryer et al.
Life Sci.
(1990)
M. Eltze
Eur. J. Pharmacol.
(1988)

P.P.A. Humphrey et al.

Trends Pharmacol. Sci.

(1993)

S.M. Lanier et al.

J. Biol. Chem.

(1991)

A.L. Tucker et al.

FEBS Lett.

(1992)

M.E. Olah et al.

J. Biol. Chem.

(1992)

Cited by (84)

The influences of the structure and activity of biologically active compounds on the assessment of inventive step
2009, World Patent Information
The assessment of inventive step for (biologically) active organic chemical compounds is discussed in the light of the application of well-established structure–activity-relationship theory as an important part of the common general knowledge. Applying the problem–solution approach (PSA), several relevant decisions of the Technical Boards of Appeal of the European Patent Office are discussed and the relevance of the PSA in this particular technical field is documented.
Structure-activity studies on neuropeptide S: Identification of the amino acid residues crucial for receptor activation
2006, Journal of Biological Chemistry
Citation Excerpt :
It is therefore possible that peptide fragment 1–10 represents the minimum active sequence for the hNPSR, but not for the mouse NPSR ortholog. However, this possibility seems to be unlikely because, in general, natural peptides do not discriminate between species-specific receptor orthologs, whereas this feature is quite characteristic of non-peptide ligands (19). Future studies are required to identify the reasons underlying the different actions of hNPS-(1–10) in vitro and in vivo.
Neuropeptide S (NPS) has been recently recognized as the endogenous ligand for the previous orphan G-protein-coupled receptor GPR154, now referred to as the NPS receptor (NPSR). The NPS-NPSR receptor system regulates important biological functions such as sleeping/wakening, locomotion, anxiety, and food intake. To collect information on the mechanisms of interaction between NPS and its receptor, a classical structure-activity relationship study was performed. Human (h) NPS derivatives obtained by Ala and d-scan and N- and C-terminal truncation were assessed for their ability to stimulate calcium release in HEK293 cells expressing the human recombinant NPSR. The results of this study indicate that (i) the effect of hNPS is mimicked by the fragment hNPS-(1–10); (ii) Phe², Arg³, and Asn⁴ are crucial for biological activity; (iii) the sequence Thr⁸-Gly⁹-Met¹⁰ is important for receptor activation, although with non-stringent chemical requirements; and (iv) the sequence Val⁶-Gly⁷ acts as a hinge region between the two above-mentioned domains. However, the stimulatory effect of hNPS given intracerebroventricularly on mouse locomotor activity was not fully mimicked by hNPS-(1–10), suggesting that the C-terminal region of the peptide maintains importance for in vivo activity. In conclusion, this study identified the amino acid residues of this peptide most important for receptor activation.
Conserved serine residues in serotonin transporter contribute to high-affinity cocaine binding
2006, Biochemical and Biophysical Research Communications
Serotonin transporter (SERT) is one of the key protein targets of cocaine. Despite intensive studies, it is not clear where cocaine binds to its targets and what residues are involved in cocaine binding. We have cloned the serotonin transporter from silkworm (Bombyx mori, bmSERT). When expressed in cultured cells, bmSERT is over 20-fold less sensitive to cocaine than Drosophila melanogaster SERT (dmSERT). We performed species-scanning mutagenesis using bmSERT and dmSERT. There are two adjacent threonine residues in transmembrane domain 12 of bmSERT where the corresponding residues are two serines in dmSERT and in all known mammalian monoamine transporters. Replacing the serine residues with threonines in dmSERT reduces cocaine sensitivity; while switching the two threonine residues in bmSERT to serines increased cocaine sensitivity. Mutations at the corresponding residues in dopamine transporter also changed cocaine affinity. Our results suggest that the conserved serine residues in SERT contribute to high-affinity cocaine binding.
A 25 year adventure in the field of tachykinins
2004, Peptides
Several aspects of our 25 year adventure in the field of tachykinins will be successively described. They concern: substance P (SP) synthesis and release in the basal ganglia, the identification and pharmacological characterization of central tachykinin NK₁, NK₂ and NK₃ binding sites and their topographical distribution, the description of some new biological tests for corresponding receptors, the identification of tachykinin NK₁ receptor subtypes or conformers sensitive to all endogenous tachykinins (substance P, neurokinin A (NKA), neurokinin B (NKB), neuropeptide γ (NPγ) and neuropeptide K (NPK)) and finally, the functional involvement of these receptors and their subtypes in tachykinin-induced regulations of dopamine and acetylcholine release in the striatum.
Muscarinic receptors in the mammalian heart
2001, Pharmacological Research
In the mammalian heart, cardiac function is under the control of the sympathetic and parasympathetic nervous system. All regions of the mammalian heart are innervated by parasympathetic (vagal) nerves, although the supraventricular tissues are more densely innervated than the ventricles. Vagal activation causes stimulation of cardiac muscarinic acetylcholine receptors (M-ChR) that modulate pacemaker activity via I_fand I_K.ACh, atrioventricular conduction, and directly (in atrium) or indirectly (in ventricles) force of contraction. However, the functional response elicited by M-ChR-activation depends on species, age, anatomic structure investigated, and M-ChR-agonist concentration used. Among the five M-ChR-subtypes M₂-ChR is the predominant isoform present in the mammalian heart, while in the coronary circulation M₃-ChR have been identified. In addition, evidence for a possible existence of an additional, not M₂-ChR in the heart has been presented. M-ChR are subject to regulation by G-protein-coupled-receptor kinase. Alterations of cardiac M₂-ChR in age and various kinds of disease are discussed.
Discovery of subtype-selective metabotropic glutamate receptor ligands using functional HTS assays
2000, Drug Discovery Today
Recent research in the area of metabotropic glutamate receptors suggests that subtype-selective modulators of individual family members could be promising candidates for a variety of nervous system disorders including pain, neurodegeneration and numerous psychiatric diseases. Relatively few subtype-selective metabotropic glutamate receptor ligands have been identified. This article will address how HTS can play an important role in identifying structurally novel ligands as drug leads and research tools.

View all citing articles on Scopus

¹: J. M. Hall is Research Fellow in the Pharmacology Group, Biomedical Sciences Division, King's College London, Manresa Road, London, UK SW3 6LX.

²: M. P. Caulfield is Research Fellow at the Department of Pharmacology, University College London, Gower Street, London, UK WC1E 6BT.

³: S. P. Watson is Research Fellow at the University Department of Pharmacology, Mansfield Road, Oxford, UK OX1 3QT.

View full text

Trends in Pharmacological Sciences

Receptor subtypes or species homologues: relevance to drug discovery

Abstract

Trends Pharmacol. Sci.

Neurochem. Int.

Regul. Peptides

Nature

J. Biol. Chem.

Biochem. Biophys. Res. Commun.

Biochem. Biophys. Res. Commun.

Pharmacol. Ther.

Life Sci.

Eur. J. Pharmacol.

Trends Pharmacol. Sci.

J. Biol. Chem.

FEBS Lett.

J. Biol. Chem.